Published in
Wiley, British Journal of Haematology, 3(196), p. 639-648, 2021
DOI: 10.1111/bjh.17887
Links
Tools
Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study
Journal article published in 2021 by
Alessandra Larocca 
,
Xavier Leleu,
Cyrille Touzeau ,
Joan Bladé,
Agne Paner,
María‐Victoria Mateos ,
Michele Cavo,
Christopher Maisel,
Adrían Alegre,
Albert Oriol,
Anastasios Raptis,
Paula Rodriguez‐Otero ,
Amitabha Mazumder,
Jacob Laubach ,
Omar Nadeem
and other authors.
,
Xavier Leleu,
Cyrille Touzeau ,
Joan Bladé,
Agne Paner,
María‐Victoria Mateos ,
Michele Cavo,
Christopher Maisel,
Adrían Alegre,
Albert Oriol,
Anastasios Raptis,
Paula Rodriguez‐Otero ,
Amitabha Mazumder,
Jacob Laubach ,
Omar Nadeem
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 